Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy

Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy

IntroductionImmune checkpoint inhibitor-related pneumonitis (ICIP) is a potentially life threatening immune-related adverse event (irAE), especially in non-small cell lung cancer (NSCLC) patients. Currently, the potential for increased irAE in patients who receive radiotherapy is scarcely known, alt...

Full description

Bibliographic Details
Main Authors: Feliciano Barrón, Roberto Sánchez, Marisol Arroyo-Hernández, Carolina Blanco, Zyanya L. Zatarain-Barrón, Rodrigo Catalán, Maritza Ramos-Ramírez, Andrés F. Cardona, Diana Flores-Estrada, Oscar Arrieta
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Oncology
Subjects:
checkpoint immune therapy
pneumonitis
radiotherapy
NSCLC
lung cancer
immune related adverse effects
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.570233/full

Similar Items

Similar Items